Julys da Fonseca Palmeira

Julys da Fonseca Palmeira

Auto-generated profile, based on publicly available information

Julys da Fonseca Palmeira

Laboratory of Molecular Neurovirology, Department of Pharmacy, Faculty of Health Science, University of Brasília, Brasília 70910-900, DF, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2020 in Reviews in Medical Virology
Verified
Journal Article
Open access
PDF file
MLMariana Braccialli de Loyola
Mariana Braccialli de Loyola
TRThaís Tereza Aguiar dos Reis
Thaís Tereza Aguiar dos Reis
GOGuilherme Xavier Lyra Malcher de Oliveira
Guilherme Xavier Lyra Malcher de Oliveira
JPJulys da Fonseca Palmeira
Julys da Fonseca Palmeira
GAGustavo A. Argañaraz
Gustavo A. Argañaraz
EAEnrique Argañaraz
Enrique Argañaraz
Summary: Understanding Covid‐19 pathophysiology is crucial for a better understanding of the disease and development of more effective treatments. Alpha‐1‐antitrypsin (A1AT) is a constitutive tissue protector with antiviral and anti‐inflammatory properties. A1AT inhibits SARS‐CoV‐2 infection and two of the most important proteases in the pathophysiology of Covid‐19: the transmembrane serine protease 2 (TMPRSS2) and the disintegrin and metalloproteinase 17 (ADAM17). It also inhibits the activity of inflammatory molecules, such as IL‐8, TNF‐α, and neutrophil elastase (NE). TMPRSS2 is essential for SARS‐CoV‐2‐S protein priming and viral infection. ADAM17 mediates ACE2, IL‐6R, and TNF‐α shedding. ACE2 is the SARS‐CoV‐2 entry receptor and a key component for the balance of the renin‐angiotensin system, inflammation, vascular permeability, and pulmonary homeostasis. In addition, clinical findings indicate that A1AT levels might be important in defining Covid‐19 outcomes, potentially partially explaining associations with air pollution and with diabetes. In this review, we focused on the interplay between A1AT with TMPRSS2, ADAM17 and immune molecules, and the role of A1AT in the pathophysiology of Covid‐19, opening new avenues for investigating effective treatments.

27 December 2020 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
GAGustavo A. Argañaraz
Gustavo A. Argañaraz
JPJulys da Fonseca Palmeira
Julys da Fonseca Palmeira
EAEnrique Argañaraz
Enrique Argañaraz
The rapid ability of SARS-CoV-2 to spread among humans, along with the clinical complications of coronavirus disease 2019—COVID-19, have represented a significant challenge to the health management systems worldwide. The acute inflammation and coagulation abnormalities appear as the main causes for thousands of deaths worldwide. The intense inflammatory response could be involved with the formation of thrombi. For instance, the presence of uncleaved large multimers of von Willebrand (vWF), due to low ADAMTS13 activity in plasma could be explained by the inhibitory action of pro-inflammatory molecules such as IL-1β and C reactive protein. In addition, the damage to endothelial cells after viral infection and/or activation of endothelium by pro-inflammatory cytokines, such as IL-1β, IL-6, IFN-γ, IL-8, and TNF-α induces platelets and monocyte aggregation in the vascular wall and expression of tissue factor (TF). The TF expression may culminate in the formation of thrombi, and activation of cascade by the extrinsic pathway by association with factor VII. In this scenario, the phosphatidylserine—PtdSer exposure on the outer leaflet of the cell membrane as consequence of viral infection emerges as another possible underlying mechanism to acute immune inflammatory response and activation of coagulation cascade. The PtdSer exposure may be an important mechanism related to ADAM17—mediated ACE2, TNF-α, EGFR and IL-6R shedding, and the activation of TF on the surface of infected endothelial cells. In this review, we address the underlying mechanisms involved in the pathophysiology of inflammation and coagulation abnormalities. Moreover, we introduce key biochemical and pathophysiological concepts that support the possible participation of PtdSer exposure on the outer side of the SARS-CoV-2 infected cells membrane, in the pathophysiology of COVID-19.

26 May 2023 in Viruses
Verified
Journal Article
Open access
PDF file
FOFernanda Bellaniza Caminha de Oliveira
Fernanda Bellaniza Caminha de Oliveira
VFVanessa Sa Freire
Vanessa Sa Freire
Sharton Vinicius Antunes CoelhoSharton Vinicius Antunes Coelho
Sharton Vinicius Antunes Coelho
LMLana Monteiro Meuren
Lana Monteiro Meuren
JPJulys da Fonseca Palmeira
Julys da Fonseca Palmeira
EAEnrique Argañaraz
Enrique Argañaraz
In recent years, the Zika Virus (ZIKV) has caused pandemic outbreaks associated with a high rate of congenital ZIKV syndrome (CZS). Although all strains associated with worldwide outbreaks derive from the Asian lineage, the reasons for their enhanced spread and severity are not fully understood. In this study, we conducted a comparative analysis of miRNAs (miRNA-155/146a/124) and their cellular targets (SOCS1/3, SHP1, TRAF6, IRAK1), as well as pro- and anti-inflammatory and anti-viral cytokines (IL-6, TNF-α, IFN-γ, IL-10, and IFN-β) and peroxisome proliferator-activated receptor γ (PPAR-γ) expression in BV2 microglia cells infected with ZIKV strains derived from African and Asian lineages (ZIKVMR766 and ZIKVPE243). BV2 cells were susceptible to both ZIKV strains, and showed discrete levels of viral replication, with delayed release of viral particles without inducing significant cytopathogenic effects. However, the ZIKVMR766 strain showed higher infectivity and replicative capacity, inducing a higher expression of microglial activation markers than the ZIKVPE243 strain. Moreover, infection with the ZIKVMR766 strain promoted both a higher inflammatory response and a lower expression of anti-viral factors compared to the ZIKVPE243 strain. Remarkably, the ZIKKPE243 strain induced significantly higher levels of the anti-inflammatory nuclear receptor—PPAR-γ. These findings improve our understanding of ZIKV-mediated modulation of inflammatory and anti-viral innate immune responses and open a new avenue to explore underlining mechanisms involved in the pathogenesis of ZIKV-associated diseases.

25 April 2025 in Viruses
Verified
Journal Article
Open access
PDF file
BMBruno Pereira de Melo
Bruno Pereira de Melo
JSJhéssica Adriane Mello da Silva
Jhéssica Adriane Mello da Silva
MRMariana Alves Rodrigues
Mariana Alves Rodrigues
JPJulys da Fonseca Palmeira
Julys da Fonseca Palmeira
FSFelipe Saldanha-araujo
Felipe Saldanha-araujo
EAEnrique Argañaraz
Enrique Argañaraz
SARS-CoV-2 infection has resulted in more than 700 million cases and nearly 7 million deaths worldwide. Although vaccination efforts have effectively reduced mortality and transmission rates, a significant proportion of recovered patients—up to 40%—develop long COVID syndrome (LC) or post-acute sequelae of COVID-19 infection (PASC). LC is characterized by the persistence or emergence of new symptoms following initial SARS-CoV-2 infection, affecting the cardiovascular, neurological, respiratory, gastrointestinal, reproductive, and immune systems. Despite the broad range of clinical symptoms that have been described, the risk factors and pathogenic mechanisms behind LC remain unclear. This review, the first of a two-part series, is distinguished by the discussion of the role of the SARS-CoV-2 spike protein in the primary mechanisms underlying the pathophysiology of LC.

9 June 2019 in Reviews in Medical Virology
Verified
Journal Article
Closed access
PDF file
JPJulys da Fonseca Palmeira
Julys da Fonseca Palmeira
GAGustavo A. Argañaraz
Gustavo A. Argañaraz
GOGuilherme Xavier Lyra Malcher de Oliveira
Guilherme Xavier Lyra Malcher de Oliveira
EAEnrique Argañaraz
Enrique Argañaraz

25 April 2025 in Viruses
Verified
Journal Article
Open access
PDF file
BMBruno Pereira de Melo
Bruno Pereira de Melo
JSJhéssica Adriane Mello da Silva
Jhéssica Adriane Mello da Silva
MRMariana Alves Rodrigues
Mariana Alves Rodrigues
JPJulys da Fonseca Palmeira
Julys da Fonseca Palmeira
AAAngélica Amorim Amato
Angélica Amorim Amato
EAEnrique Argañaraz
Enrique Argañaraz
SARS-CoV-2 infection has had a significant impact on global health through both acute illness, referred to as coronavirus disease 2019 (COVID-19), and chronic conditions (long COVID or post-acute sequelae of COVID-19, PASC). Despite substantial advancements in preventing severe COVID-19 cases through vaccination, the rise in the prevalence of long COVID syndrome and a notable degree of genomic mutation, primarily in the S protein, underscores the necessity for a deeper understanding of the underlying pathophysiological mechanisms related to the S protein of SARS-CoV-2. In this review, the latest part of this series, we investigate the potential pathophysiological molecular mechanisms triggered by the interaction between the spike protein and cellular receptors. Therefore, this review aims to provide a differential and focused view on the mechanisms potentially activated by the binding of the spike protein to canonical and non-canonical receptors for SARS-CoV-2, together with their possible interactions and effects on the pathogenesis of long COVID.